Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection

Digestive and Liver Disease

Volumn 39, Issue 6, 2007, Pages 516-523

  Myllyluoma, E ^a,b   Kajander, K ^a,c   Mikkola, H ^c   Kyronpalo S ^d   Rasmussen, M ^d   Kankuri, E ^a,e   Sipponen, P ^f   Vapaatalo, H ^a   Korpela, R ^a,b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FOUNDATION FOR NUTRITION RESEARCH   (Finland)

^c VALIO LTD   (Finland)

^d Tampere City Hospital   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f JORVI HOSPITAL   (Finland)

Author keywords

Adhesion; Gastrointestinal mucosa; Helicobacter pylori; Probiotics

Indexed keywords

CARBON 13; GASTRIN 17; PEPSINOGEN I; PEPSINOGEN II; PROBIOTIC AGENT; UREASE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BIFIDOBACTERIUM ANIMALIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; COLONY FORMING UNIT; CONTROLLED STUDY; DUODENOSCOPY; DUODENUM; ENZYME ACTIVITY; FECES ANALYSIS; FEMALE; FLUID INTAKE; GASTRITIS; GASTROINTESTINAL MUCOSA; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LACTOBACILLUS RHAMNOSUS; MALE; OUTCOME ASSESSMENT; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; PROPIONIBACTERIUM FREUDENREICHII; QUANTITATIVE ANALYSIS; STOMACH ANTRUM; STOMACH BIOPSY; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; TREATMENT OUTCOME; UREA BREATH TEST;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; DNA, BACTERIAL; FECES; FEMALE; GASTRIC MUCOSA; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGENS; PROBIOTICS;

EID: 34248575238     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.02.015     Document Type: Article

References (47)

1. Fox J.G., and Wang T.C. Helicobacter pylori-not a good bug after all!. N Engl J Med 345 (2001) 829-832
2. Conway P.L., Gorbach S.L., and Goldin B.R. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 70 (1987) 1-12
3. Marteau P., Minekus M., Havenaar R., and Huis int't Veld J.H. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci 80 (1997) 1031-1037
4. Gotteland M., Brunser O., and Cruchet S. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?. Aliment Pharmacol Ther 23 (2006) 1077-1086
5. Fox J.G., and Wang T.C. Helicobacter pylori: pathogenesis. Curr Opin Gastroenterol 18 (2002) 15-25
6. Sipponen P., Ranta P., Helske T., Kääriäinen I., Mäki T., Linnala A., et al. Serum levels of amidated gastrin-17 and pepsinogens I in atrophic gastritis. An observational case-control study. Scand J Gastroenterol 37 (2002) 785-791
7. Gritti I., Banfi G., and Roi G.S. Pepsinogens: physiology, pharmacology pathophysiology and exercise. Pharmacol Res 41 (2000) 265-281
8. Perez-Paramo M., Albillos A., Calleja J.L., Salas C., Marin M.C., Marcos M.L., et al. Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy. Dig Dis Sci 42 (1997) 1734-1740
9. Sokic-Milutinovic A., Todorovic V., Milosavljevic T., Micev M., Drndarevic N., and Mitrovic O. Gastrin and antral G cells in course of Helicobacter pylori eradication: six months follow up study. World J Gastroenterol 11 (2005) 4140-4147
10. Wagner S., Haruma K., Gladziwa U., Soudah B., Gebel M., Bleck J., et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroenterol 89 (1994) 1211-1218
11. Wang K.Y., Li S.N., Liu C.S., Perng D.S., Su Y.C., Wu D.C., et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 80 (2004) 737-741
12. Cats A., Kuipers E.J., Bosschaert M.A., Pot R.G., Vandenbroucke-Grauls C.M., and Kusters J.G. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther 17 (2003) 429-435
13. Coconnier M.H., Lievin V., Hemery E., and Servin A.L. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 64 (1998) 4573-4580
14. Cruchet S., Obregon M.C., Salazar G., Diaz E., and Gotteland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 19 (2003) 716-721
15. Felley C.P., Corthesy-Theulaz I., Rivero J.L., Sipponen P., Kaufmann M., Bauerfeind P., et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 13 (2001) 25-29
16. Gotteland M., Poliak L., Cruchet S., and Brunser. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Act Pediatr 94 (2005) 1747-1751
17. Michetti P., Dorta G., Wiesel P.H., Brassart D., Verdu E., Herranz M., et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 60 (1999) 203-209
18. Pantoflickova D., Corthesy-Theulaz I., Dorta G., Stolte M., Isler P., Rochat F., et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis. Aliment Pharmacol Ther 18 (2003) 805-813
19. Sykora J., Valecková K., Amlerová J., Siala K., Decek P., Watkins S., et al. Effects of a specially designed fermented milk product containing probiotic Lactobacilli casei DN-114 001 and the eradication of H. pylori in children. J Clin Gastroenterol 39 (2005) 692-698
20. Sakamoto I., Igarashi M., Kimura K., Takagi A., Miwa T., and Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 47 (2001) 709-710
21. Myllyluoma E., Veijola L., Ahlroos T., Tynkkynen S., Kankuri E., Vapaatalo H., et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy-a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Therapy 21 (2005) 1263-1272
22. Myllyluoma E., Ahlroos T., Veijola L., Rautelin H., Tynkkynen S., and Korpela R. Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. Int J Antimicrob Agents 29 (2007) 66-72
23. Dixon M.F., Genta R., Yardley J.H., and Correa P. Classification and grading of gastritis: the updated Sydney System. Am J Surg Pathol 20 (1996) 1161-1181
24. Gatta L., Vakil N., Ricci C., Osborn J.F., Tampieri A., Perna F., et al. A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment. Aliment Pharmacol Ther 17 (2003) 793-798
25. Veijola L., Myllyluoma E., Korpela R., and Rautelin H. Stool antigen tests in the diagnosis of Helicobacter pylori infection before and after eradication therapy. World J Gastroenterol 11 (2005) 7340-7344
26. Walter J., Hertel C., Tannock G.W., Lis C.M., Munro K., and Hammes W.P. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67 (2001) 2578-2585
27. Halme T, Suoniemi A, Tynkkynen S. Strain specific identification of Lactobacillus rhamnosus GG and LC705 from faecal samples [abstract]. FEMS Seventh Symposium on Lactic Acid Bacteria - Genetics, Metabolism and Applications, 2002; p. B41.
28. Mikkola H, Myllyluoma E, Ahlroos T, Tynkkynen S. Quantification of probiotic strains in faecal samples by real-time PCR [abstract]. IUFOST 13th World Congress of Food Science and Technology-Food is Life, 2006; p. 286.
29. Ventura M., Reniero R., and Zink R. Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Appl Environ Microbiol 67 (2001) 2760-2765
30. Schubert M.L. Regulation of gastric acid secretion. Curr Opin Gastroenterol 15 (1999) 457
31. Morita H., He F., Fuse T., Ouwehand A.C., Hashimoto H., Hosoda M., et al. Adhesion of lactic acid bacteria to Caco-2 cells and their effect on cytokine secretion. Microbiol Immunol 46 (2002) 293-297
32. Peña J.A., and Versalovic J. Lactobacillus rhamnosus GG decreases TNF-α production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cellul Microbiol 5 (2003) 277-285
33. Zhang L., Li N., Caicedo R., and Neu J. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 135 (2005) 1752-1756
34. Walter S.A., Grabowska A.M., El-Zaatari M., and Takhar A. Gastrin-active participant or bystander in gastric carcinogenesis?. Nat Rev Cancer 6 (2006) 936-946
35. Mottet C., and Michetti P. Probiotics: wanted dead or alive. Dig Liv Dis 37 (2005) 3-6
36. Gueimonde M., and Salminen S. New methods for selecting and evaluating probiotics. Dig Liv Dis 38 (2006) S242-S247
37. Huijsdens X., Linskens R., Mak M., Meuwissen S., Vandenbroucke-Grauls C., and Savelkoul P. Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol 40 (2002) 4423-4427
38. Ott S.J., Musfeldt N., Wenderoth D.F., Hampe J., Brant O., Fölsch U.R., et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53 (2004) 685-693
39. Bik E.M., Eckburg P.B., Gill S.R., Nelson K.E., Purdom E.A., Francois F., et al. Molecular analysis of the bacterial microbiota in the human stomach. PNAS 103 (2006) 732-737
40. Tuomola E.M., and Salminen S.J. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 41 (1998) 45-51
41. Tuomola E.M., Ouwehand A.C., and Salminen S.J. Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins. Int J Food Microbiol 60 (2000) 75-81
42. Roos S., Engstrand L., and Johnsson H. Lactobacillus gastricus sp. nov., Lactobacillus antri sp. nov., Lactobacillus kalixensis sp. nov. and Lactobacillus ultunensis sp. nov., isolated from human stomach mucosa. Int J Syst Evol Microbiol 55 (2005) 77-82
43. Valeur N., Engel P., Carbajal N., Connolly E., and Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 70 (2006) 1176-1181
44. Fujimura S., Kato S., Oda M., Miyahara M., Ito Y., Kimura K., et al. Detection of Lactobacillus gasseri OLL2716 strain administered with yogurt drink in gastric mucus layer in humans. Lett Appl Microbiol 43 (2006) 578-581
45. Di Mario F., Cavallaro L.G., Moussa A.M., Caruana P., Merli R., Maini A., et al. Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci 51 (2006) 1791-1795
46. Perri F., Clemente R., Pastore M., Quitadamo M., Festa V., Bisceglia M., et al. The 13C-urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scan J Clin Lab Invest 58 (1998) 19-28
47. Zagari R.M., Pozzato P., Martuzzi C., Fuccio L., Martinelli G., Roda E., et al. 13C-Urea breath test to assess Helicobacter pylori bacterial load. Helicobacter 10 (2005) 615-619